HomeInvestors HealthEli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) Eli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) By BOMAR ENT. February 16, 2025 FacebookTwitterPinterestWhatsApp Andrew Harnik/Getty Images News Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the Department of Health Source link Previous articleAre Our Predictions Already Wrong?Next articleTHE PATH TO SUCCESS IN TRADING latest articles explore more Black Hills’ Unit Receives Approval for Rate Hike in Colorado – March 25, 2025 Millionaire Mission: A 9-Step System to Level Up Your Finances and Build Wealth Entero Therapeutics slips 7%, signs rescission agreement with ImmunogenX Financial Fractals: A Practical Guide to Master the Chaos Young Americans Are Increasingly Moving to Rural Markets Become a MASTER in Technical Analysis of Stock Market Charts LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
